Key result
Sirolimus-eluting stents resulted in a significantly different change in mean lumen area at the distal stent edge compared to bare-metal stents (0.2 vs -0.8 mm2; p=0.04) at 9 months.
Why the study?
Does sirolimus-eluting stent implantation compared to bare-metal stent implantation improve coronary plaque composition and lumen dimensions at stent edges in patients with acute myocardial infarction?
Cohort (n=40)
Does sirolimus-eluting stent implantation compared to bare-metal stent implantation improve coronary plaque composition and lumen dimensions at stent edges in patients with acute myocardial infarction?
Absolute Event Rate: 0.2% vs -0.8%
p-value: p=0.04
Sirolimus-eluting stents significantly reduce neointima volume and preserve distal mean lumen area compared to bare-metal stents in AMI patients at 9 months, though neither affects plaque composition.
AIMS: To evaluate effects of sirolimus-eluting stents (SES) compared to bare-metal stents (BMS) at stent edges in patients with acute myocardial infarction (AMI). METHODS AND RESULTS: Clinical, angiographic, intravascular ultrasound (lVUS) and virtual histology (VH)-IVUS results were obtained and analysed in 20 SES and 20 BMS AMI patients at the index procedure and at nine months follow-up. Quantitative angiography and IVUS showed a trend toward decreases in mean lumen diameter, vessel volume, minimum lumen area and mean lumen area at both stent edges of BMS, and at the proximal edge of SES. At the distal stent edge, a significant difference between BMS and SES treated patients in mean lumen area was found (D-0.8+/-1.6 mm2 versus D0.2+/-0.8 mm2 respectively, p=0.04). Furthermore, in-stent SES had a larger lumen volume (SES: 167.7+/-59.2 mm3 versus BMS: 125.1+/-43.8 mm3; p=0.02) and less neointima volume (7.3+/-9.1 mm3 versus 53.2+/-35.1 mm3; p<0.001). Neither SES nor BMS demonstrated a significant effect on plaque composition at follow-up VH-IVUS analysis. CONCLUSIONS: A significant difference between SES and BMS treated patients was observed with respect to mean lumen diameter distal to the stented segment which suggests a downstream effect of sirolimus elution.
No takes yet. Share an insight, caveat, or question.
Atary et al. (2009) conducted a cohort in Acute myocardial infarction (AMI) (n=40). Sirolimus-eluting stents (SES) vs. Bare-metal stents (BMS) was evaluated on Change in mean lumen area at the distal stent edge (p=0.04). Sirolimus-eluting stents resulted in a significantly different change in mean lumen area at the distal stent edge compared to bare-metal stents (0.2 vs -0.8 mm2; p=0.04) at 9 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: